| HOME >> MEDICINE >> TECHNOLOGY |
$
383.5$
344.511.3 %Adjusted Income From Operations (1)
$
21.5$
.89.7 %Adjusted Net Income (1)
$
91.4$
85.07.5 %Adjusted Diluted Earnings Per Share (1)
$
.55$
.517.8 %Statistics (as a % of net sales, except for income tax rate):GAAP Three Months Ended December 31, Adjusted(1) Three Months Ended December 31,2012201120122011Gross Profit (2)28.6 %27.7 %34.9 %34.0 %Income (Loss) From Operations
2.8 %(20.9)%11.1 %10.9 %Net Income (Loss)0.5 %(21.1)%8.3 %8.4 %Income Tax Rate 137.5 %4.4 %16.3 %15.2 %(1)
Adjusted financial measures exclude certain specified items as described and reconciled to comparable GAAP financial measures in the Reconciliation of GAAP to Non-GAAP Financial Measures contained in this press release.(2)
Gross profit is defined as Net sales less Cost of products sold. Adjusted gross profit excludes certain specified items, as indicated in the previous footnote.nm - Percentage change is not meaningful. Hospira, Inc.Condensed Consolidated Statements of Income (Loss)(Unaudited)(dollars and shares in millions, except for per share amounts)Years Ended December 31,% Change20122011Net sales
$
4,092.1$
4,057.10.9 %Cost of products sold
2,978.72,659.512.0 %Restructuring, impairment and (gain) on disposition of assets, net
63.344.542.2 %Goodwill impairment
—400.2nmResearch and development
303.6258.817.3 %Selling, general and administrative
687.7637.37.9 %Total operating costs and expenses
4,033.34,000.30.8 %Income From Operations
58.856.83.5 %Interest expense
86.393.1(7.3)%Other expense (income), net
14.4(9.2)256.5 %(Loss) Before Income Taxes
(41.9)(27.
'/>"/>
| SOURCE Hospira, Inc. Copyright©2012 PR Newswire. All rights reserved |